Skip to nav Skip to content

IDSA Media Briefing: Paxlovid – Updates on Its Use and Availability

Facebook Twitter LinkedIn Email

A media briefing from experts from the Infectious Diseases Society of America to discuss recently issued practice guidelines on Paxlovid and interactions with other commonly prescribed medications.

- Paxlovid and drug interactions – common misunderstandings
- Current availability
- Improving equity, access, and infrastructure
- Questions from media

Jason C. Gallagher, PharmD, FCCP, FIDP, FIDSA, BCPS—Philadelphia, PA
Member—IDSA COVID-19 Treatment and Management Guidelines Expert Panel
Clinical Professor, Temple University
Clinical Specialist, Infectious Diseases, Temple University
Director, PGY2 Residency in Infectious Diseases Pharmacy, Temple University

Melanie Thompson, MD –Atlanta, GA
Co-chair—HIVMA/IDSA HIV Primary Care Guidance Panel
Past Chair—HIVMA
Member, HHS Antiretroviral Guidelines Panel, IAS-USA Antiretroviral Guidelines Panel
Past Principal Investigator, AIDS Research Consortium of Atlanta

Chris Busky, CAE (Moderator)
Chief Executive Officer—Infectious Diseases Society of America

This website uses cookies

We use cookies to ensure that we give you the best experience on our website. Cookies facilitate the functioning of this site including a member login and personalized experience. Cookies are also used to generate analytics to improve this site as well as enable social media functionality.